EP News
- Thu, 4/26/12 - 10:37am
- 0 Comments
- 295 reads
New Radiation Protection Products Approved for Device Implants
LEMER PAX announced the CE Mark and market release of three new versions of its CATHPAX Radiation Protection Cabin. Like the original CATHPAX radiation cabin, which was designed for ablation procedures, the new devices provide greater than 99.9% protection from scatter radiation.
EP News
- Fri, 3/23/12 - 3:27pm
- 0 Comments
- 719 reads
Asahi Kasei Announces Agreement to Acquire ZOLL Medical
Asahi Kasei Corporation and ZOLL Medical Corporation jointly announced that Asahi Kasei, Japan’s leading diversified chemical manufacturer with businesses in the health care, chemicals and fibers, homes and construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion. The transaction has been approved by the Boards of Directors of both companies.
EP News
- Wed, 2/29/12 - 12:13pm
- 0 Comments
- 828 reads
Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive™ System
Stereotaxis, Inc. announced that its Vdrive™ Robotic Navigation System, which provides physicians the ability to remotely manipulate traditionally non-robotic catheters, is growing in popularity and is expected to surpass 500 clinical procedures in Europe in February. The company also announced it has received regulatory clearance from Health Canada to commercially market the device in Canada.
News
- Fri, 1/27/12 - 1:15pm
- 0 Comments
- 1258 reads
Biosense Webster Announces FDA Approval of the ThermoCool® SF Catheter in the United States
Biosense Webster, Inc. announced the FDA approval of the new ThermoCool® SF irrigated ablation catheter in the United States.
The ThermoCool® SF NAV Catheter combines Biosense Webster’s latest irrigated ablation technology with the accurate visualization of the Carto®3 3D Mapping & Ablation System. The catheter was launched in Europe in October 2010, and has received excellent feedback from electrophysiologists who have used the product.
News
- Thu, 12/1/11 - 12:18pm
- 0 Comments
- 1324 reads
FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
The U.S. Food and Drug Administration approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation).
Atrial fibrillation occurs in more than 2 million Americans and is one of the most common types of abnormal heart rhythm. In atrial fibrillation, the beating of the heart’s two upper heart chambers is irregular and poorly coordinated.
News
- Thu, 10/27/11 - 3:50pm
- 0 Comments
- 1689 reads
Medtronic Announces Results from TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation
Medtronic, Inc. announced results from its Tailored Treatment of Permanent Atrial Fibrillation (TTOP-AF) clinical trial, the first randomized study comparing ablation therapy with the Medtronic Phased RF Ablation System ablation system to traditional medical management (antiarrhythmic drugs and direct current cardioversion) in 210 patients with persistent or longstanding persistent atrial fibrillation (AF).
News
- Wed, 9/28/11 - 3:57pm
- 0 Comments
- 1496 reads
FDA Clears New Rapid, Large-Area, and Radiopaque Temperature Sensing Probe and System
CIRCA Scientific announced that its CIRCA S-CATH™ and CIRCA Temperature Monitoring System™ have received 510(k) clearance in the U.S. by the Food and Drug Administration (FDA).
The CIRCA S-CATH and the CIRCA Temperature Monitoring System address the problems associated with slow, single sensor, and small surface area standard esophageal temperature probes and monitors.
News
- Wed, 8/31/11 - 11:05am
- 0 Comments
- 1657 reads
HeartLight™ Endoscopic Ablation System Now Available in the UK
CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that the HeartLight EAS is now available in the United Kingdom. The first AF patients were treated at The Heart Hospital in London on Wednesday, August 17, with additional cases to take place throughout the month.
News
- Thu, 7/28/11 - 10:28am
- 0 Comments
- 2135 reads
Biosense Webster Enrolls First Patient in Groundbreaking SMART-AF Trial
Biosense Webster, Inc. announced the enrollment of the first patient in their latest groundbreaking clinical trial, the SMART-AF Investigational Device Exemption (IDE) study, and the treatment of the first patient with the new ThermoCool® SmartTouch™ Contact Force Sensing Catheter and Software Module in the United States.
News
- Thu, 6/30/11 - 4:36pm
- 0 Comments
- 2596 reads
Cardiovascular Credentialing International to Sunset On-the-Job Training as Qualification Pathway for Invasive Registry Examination
Effective July 1, 2013, Cardiovascular Credentialing International (CCI) will officially remove the RCIS1 Qualification (also referred to as the On-the-Job Training qualification) that allows applicants who only have two years (full-time or full-time equivalent) working in Invasive Cardiovascular Technology, at the time of application, to qualify for CCI's Invasive Registry examination. The Invasive Registry examination is the required examination for the Registered Cardiovascular Invasive Specialist (RCIS) credential.
